United States of America, The States of California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Oklahoma, Rhode Island, Tennessee, Texas, Vermont, Virginia, Washington, Wisconsin, The City of Chicago, and The City of New York ex rel. Omni Healthcare Inc. v. McKesson Corporation and Oncology Therapeutics Network Corporation

CourtDistrict Court, E.D. New York
DecidedJanuary 27, 2026
Docket1:12-cv-06440
StatusUnknown

This text of United States of America, The States of California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Oklahoma, Rhode Island, Tennessee, Texas, Vermont, Virginia, Washington, Wisconsin, The City of Chicago, and The City of New York ex rel. Omni Healthcare Inc. v. McKesson Corporation and Oncology Therapeutics Network Corporation (United States of America, The States of California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Oklahoma, Rhode Island, Tennessee, Texas, Vermont, Virginia, Washington, Wisconsin, The City of Chicago, and The City of New York ex rel. Omni Healthcare Inc. v. McKesson Corporation and Oncology Therapeutics Network Corporation) is published on Counsel Stack Legal Research, covering District Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States of America, The States of California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Oklahoma, Rhode Island, Tennessee, Texas, Vermont, Virginia, Washington, Wisconsin, The City of Chicago, and The City of New York ex rel. Omni Healthcare Inc. v. McKesson Corporation and Oncology Therapeutics Network Corporation, (E.D.N.Y. 2026).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK --------------------------------------------------------- x

UNITED STATES OF AMERICA, THE STATES OF CALIFORNIA, COLORADO, CONNECTICUT, DELAWARE, OPINION & ORDER DISTRICT OF COLUMBIA, FLORIDA, GEORGIA, HAWAII, ILLINOIS, 12-cv-6440 (NG) (ST) INDIANA, IOWA, LOUISIANA, MARYLAND, MASSACHUSETTS, MICHIGAN, MINNESOTA, MONTANA, NEVADA, NEW HAMPSHIRE, NEW JERSEY, NEW MEXICO, NEW YORK, NORTH CAROLINA, OKLAHOMA, RHODE ISLAND, TENNESSEE, TEXAS, VERMONT, VIRGINIA, WASHINGTON, WISCONSIN, THE CITY OF CHICAGO, AND THE CITY OF NEW YORK ex rel. OMNI HEALTHCARE INC., Plaintiffs, -against- MCKESSON CORPORATION AND ONCOLOGY THERAPEUTICS NETWORK CORPORATION, Defendants. --------------------------------------------------------- x GERSHON, United States District Judge:

Relator Omni Healthcare, Inc. (“Omni”) brings this qui tam action on behalf of the United States and various state and municipal entities, alleging violations of the False Claims Act, 31 U.S.C. §§ 3729 et seq., by defendant McKesson Corporation (“McKesson”). On August 22, 2025, Omni sought a finding that McKesson had waived attorney-client privilege over certain communications and topics by introducing evidence of its subjective good faith and conversations with counsel in its moving papers on its summary judgment briefing. This, Omni argued, was in contravention of McKesson’s position that it would not do so. McKesson took this position in 2023 before the magistrate judge supervising discovery, Judge Steven Tiscione, in order to avoid a privilege waiver. After briefing and oral argument on this issue, I granted Omni’s motion on December 4, 2025 and ordered the depositions of certain McKesson witnesses to be reopened and certain withheld communications to be produced. United States v. McKesson Corp., 2025 WL

3651471 (E.D.N.Y. Dec. 4, 2025). McKesson now moves for reconsideration or certification for appeal. McKesson does not challenge my determination that it waived privilege (although it reserves the right to do so in later appellate review). McKesson limits its motion to challenging my remedial ruling that Omni is entitled to further discovery; it asks that I instead permit it to withdraw the statements that gave rise to the finding of waiver. In the alternative, it seeks certification of the remedial ruling for an interlocutory appeal. Omni, in its opposition, “cross-moves” for attorneys’ fees for responding to McKesson’s motion. For the reasons set forth below, McKesson’s motion is denied. Omni’s motion for attorneys’ fees is also denied. I. Reconsideration

Local Civil Rule 6.3 requires a party moving for reconsideration to “set[] forth concisely the matters or controlling decisions which the moving party believes the court has overlooked.” (emphasis added). “The standard for granting such a motion is strict, and reconsideration will generally be denied unless the moving party can point to controlling decisions or data that the court overlooked — matters, in other words, that might reasonably be expected to alter the conclusion reached by the court.” Shrader v. CSX Transp., Inc., 70 F.3d 255, 257 (2d Cir.1995) (emphasis added). McKesson itself recognizes this standard in its moving papers. Yet its motion for reconsideration is devoid of any controlling decisions or data that the court overlooked. It relies instead on non-controlling decisions of district courts where a privilege waiver was found but the waiving party was allowed to withdraw the arguments or defenses at issue.1 Nor does McKesson, in arguing that the court overlooked “context” in choosing the appropriate remedy, identify matters that were not considered by the court.2

Because McKesson’s motion “appears principally to express disagreement with the Court's ruling, rather than facts or controlling law the Court overlooked,” I conclude that reconsideration is not warranted. Coventry Cap. US LLC v. EEA Life Settlements Inc., 439 F. Supp. 3d 169, 177 (S.D.N.Y. 2020). II. Certification for Appeal 28 U.S.C. § 1292(b) provides that a district court may certify an interlocutory appeal if all of three criteria are met: (1) “such order involves a controlling question of law” (2) “as to which there is substantial ground for difference of opinion” and (3) “that an immediate appeal from the order may materially advance the ultimate termination of the litigation.” However, interlocutory appeals are disfavored. The Second Circuit has “repeatedly cautioned” that the use of this

1 See In re Keurig Green Mountain Single Serve Coffee Antitrust Litig., 2019 WL 2724269 (S.D.N.Y. July 1, 2019); Nelson v. Sabre Companies, LLC, 2018 WL 4030533 (N.D.N.Y. July 9, 2018); Scott v. Chipotle Mexican Grill, Inc., 67 F. Supp. 3d 607 (S.D.N.Y. 2014); MBIA Ins. Corp. v. Patriarch Partners VIII, LLC, 2012 WL 2568972 (S.D.N.Y. July 3, 2012). Not only are these cases not controlling, but they do not involve the remedial issue presented here, namely, what remedy to impose where the waiving party has already had the opportunity to withdraw a good faith defense, and has in fact done so over two years ago. Put another way, the decisions McKesson relies on are more akin to the situation before Judge Tiscione than the situation before me. Regardless, they reflect no controlling principle of law but simply each court’s exercise of discretion in the face of the facts before it.

2 It was not, as McKesson argues, the conduct of Omni that gave rise to McKesson’s waiver, nor the ruling of the court that “force[d]” it to “resurrect” its good faith defense. Defs’ Mot. for Reconsideration at 6-8. I found an implied waiver based on the conduct of McKesson, namely, that it affirmatively introduced evidence of its subjective intent and good faith in support of its summary judgment motion after unequivocally agreeing not to do so. certification procedure should be “strictly limited” because only “exceptional circumstances [will] justify a departure from the basic policy of postponing appellate review until after the entry of a final judgment.” In re Flor, 79 F.3d 281, 284 (2d Cir. 1996) (alteration in original). Put differently, § 1292(b) “is a rare exception to the final judgment rule that generally prohibits

piecemeal appeals.” Koehler v. Bank of Bermuda Ltd., 101 F.3d 863, 865 (2d Cir. 1996). Because the remedial ruling presents no controlling question of law (and McKesson does not offer any argument to the contrary), it is not appropriate for certification. A controlling question of law is one that the reviewing court “could decide quickly and cleanly without having to study the record.” In re Facebook, Inc., IPO Sec. & Derivative Litig., 986 F. Supp. 2d 524, 536 (S.D.N.Y. 2014). “Fact-dependent matters that are within the district court's discretion, such as the scope of a privilege waiver, do not involve a ‘controlling issue of law’ under § 1292(b).” Convole, Inc. v. Compaq Computer Corp, 2006 WL 2788234, at *2 (S.D.N.Y. Sept. 27, 2006). I determined the appropriate scope of the remedial ruling by carefully examining the record. That determination was a fact-bound, discretionary matter and does not pose a question of law suitable

for certification. III.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
United States of America, The States of California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Oklahoma, Rhode Island, Tennessee, Texas, Vermont, Virginia, Washington, Wisconsin, The City of Chicago, and The City of New York ex rel. Omni Healthcare Inc. v. McKesson Corporation and Oncology Therapeutics Network Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-of-america-the-states-of-california-colorado-connecticut-nyed-2026.